Israeli equity crowdfunding company OurCrowd has set up an innovation incubator in partnership with Motorola Solutions, India's Reliance Industries and Hebrew University of Jerusalem technology transfer company Yissum.
Mapping out Cancer cells and how to fight them.
Interview with Ayelet Dilion-Mashiah, NewStem CEO.
Universities in the country produce plenty of research, much of which can be turned into viable and marketable products. In that, Israel has plenty of experience: Two out of the three oldest university-based technology transfer companies in the...
Betalin Therapeutics, Nutrino Health, and E-Shunt win top awards in first ever biomed startup competition held at MIXiii Biomed exhibition this week.
Dr. Yaron Daniely, chief executive of Yissum, Hebrew University’s technology transfer arm, and himself the driving force behind many Israeli developments in medical technology, credits the amazing performance of Israeli R&D to “chutzpah,” shown...
During the recent Rethinking Food: The Future of Food Innovation event in Tel Aviv, Israel, organised by the Israel Export Institute, Dr Kevin Robinson met with Ram Reifen, a paediatric specialist in gastroenterology and nutrition and a Professor...
Cancer patients are subject to rounds of chemotherapy treatments in which cells – both healthy and cancerous are expected to be destroyed in the process.
Now Hebrew University researchers say they have developed a way to predict resistance to...
NewStem, a startup based in Jerusalem, is developing a novel diagnostic kit for predicting resistance to chemotherapy treatments. The technology is based on the pioneering research of Prof. Nissim Benvenisty of the Azrieli Center for Stem Cells...
Yissum, société de valorisation commerciale de l'université hébraïque de Jérusalem, a généré depuis 1964 près de 2 milliards de dollars de chiffre d'affaires. Si elle a misé très tôt sur les sciences de la vie, la structure a élargi son...
Soy, rice and peas still dominate the plant-based protein market, but chickpeas could soon give them all a serious run for their money, predicts Israeli start-up CHiCK.P, which is seeking a strategic partner to commercialize its patent-pending...
Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...
You’re a first-time visitor to Jerusalem, what sites are likely to arouse the strongest feelings? Naturally one would be the Western Wall, but how about the Daniel Auster Garden next to city hall?
Prof. Noam Shoval, Yonatan Schvimer and Prof....